The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland.
The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland.
复制标题
DOI：
10.3390/vaccines9040382
复制
发表时间：
2021-04-14
期刊：
影响因子：
7.8
通讯作者：
Wysocki J
中科院分区：
文献类型：
--
作者：
Rzymski P;Zeyland J;Poniedziałek B;Małecka I;Wysocki J
疫苗犹豫是COVID-19疫苗接种计划成功的主要威胁。目前对波兰成年人的横断面在线调查（n = 1020）表示愿意接受COVID-19疫苗的调查于2021年2月至3月进行，旨在评估（i）对不同类型疫苗的普遍信任，（ii）对波兰已使用的COVID-19疫苗的接受程度（BNT 162 b2由BioNTech/Pfizer提供，mRNA-1273由Moderna提供，AZD 1222由Oxford/AstraZeneca提供）以及八种在欧盟（EU）以外批准或处于临床试验后期阶段的疫苗，（iii）对COVID-19疫苗接种的恐惧程度，以及（iv）关于COVID-19疫苗接种的主要信息来源。在所有主要疫苗技术中，mRNA平台的信任度最高，相当多的受访者（>20%）不知道存在使用传统方法生产的疫苗（灭活疫苗和减毒活疫苗）。参与者的年龄是区分对特定疫苗类型信任程度的主要因素。与AZD 1222相反，BNT 162 b和mRNA-1273都获得了很高的接受度。在研究时欧盟未授权的8种疫苗中，CVnCoV（mRNA; CureVac）的信任度最高，其次是Ad26.COV2.S（载体; Janssen/约翰逊&约翰逊）和NVX-CoV 2373（蛋白质; Novavax）。Sputnik V（载体; Gamaleya研究所）无疑是最不可信的疫苗。研究组的恐惧中位数（用10分Likert类型量表测量）为4.0，主要与严重过敏反应、其他严重不良事件和疫苗接种的未知长期影响的风险有关。女性、受教育程度较低的个人以及不寻求任何COVID-19疫苗信息的人对接种疫苗的恐惧程度较高。专家的材料是研究组关于COVID-19疫苗的主要信息来源。该研究表明，生产商对COVID-19疫苗的信任程度可能存在很大差异，而mRNA疫苗的接受程度很高。它还强调，在抗击大流行病时，需要进行有效和持续的科学传播，因为这可能是提高对疫苗的普遍认识的理想时机。
Vaccine hesitancy is a major threat to the success of COVID-19 vaccination programs. The present cross-sectional online survey of adult Poles (n = 1020) expressing a willingness to receive the COVID-19 vaccine was conducted between February and March 2021 and aimed to assess (i) the general trust in different types of vaccines, (ii) the level of acceptance of the COVID-19 vaccines already in use in Poland (BNT162b2 by BioNTech/Pfizer, mRNA-1273 by Moderna and AZD1222 by Oxford/AstraZeneca) as well as eight vaccines approved outside European Union (EU) or in advanced stages of clinical trials, (iii) level of fear of vaccination against COVID-19, and (iv) main sources of information on COVID-19 vaccination. Among all major vaccine technology, the highest level of trust was observed for the mRNA platform, with a considerable number of surveyed (>20%) not aware of the existence of vaccines produced using the traditional approach (inactivated and live attenuated vaccines). The age of participants was the main factor differentiating the level of trust in a particular vaccine type. Both BNT162b and mRNA-1273 received a high level of acceptance, contrary to AZD1222. From eight vaccines unauthorized in the EU at the moment of study, the CVnCoV (mRNA; CureVac) was met with the highest level of trust, followed by Ad26.COV2.S (vector; Janssen/Johnson&Johnson) and NVX-CoV2373 (protein; Novavax). Sputnik V (vector; Gamaleya Research Institute) was decidedly the least trusted vaccine. The median level of fear (measured by the 10-point Likert-type scale) in the studied group was 4.0, mostly related to the risk of serious allergic reactions, other severe adverse events and unknown long-term effects of vaccination. Female, individuals with a lower level of education and those not seeking any information on the COVID-19 vaccines revealed a higher fear of vaccination. Experts’ materials were the major source of information on COVID-19 vaccines in the studied group. The study shows the level of trust in COVID-19 vaccines can vary much across the producers while the mRNA vaccines are received with a high level of acceptance. It also emphasizes the need for effective and continuous science communication when fighting the pandemic as it may be an ideal time to increase the general awareness of vaccines.
登录
查看更多内容
影响因子：
3.3
作者：
Ferdinand, Keith C.;Nedunchezhian, Saihariharan;Reddy, Tina K.
通讯作者：
Reddy, Tina K.
DOI：
10.1056/nejmoa2035389
发表时间：
2021-02-04
期刊：
The New England journal of medicine
影响因子：
--
作者：
Baden LR;El Sahly HM;Essink B;Kotloff K;Frey S;Novak R;Diemert D;Spector SA;Rouphael N;Creech CB;McGettigan J;Khetan S;Segall N;Solis J;Brosz A;Fierro C;Schwartz H;Neuzil K;Corey L;Gilbert P;Janes H;Follmann D;Marovich M;Mascola J;Polakowski L;Ledgerwood J;Graham BS;Bennett H;Pajon R;Knightly C;Leav B;Deng W;Zhou H;Han S;Ivarsson M;Miller J;Zaks T;COVE Study Group
通讯作者：
COVE Study Group
影响因子：
3.7
作者：
Dube, Eve;Gagnon, Dominique;MacDougall, Heather
通讯作者：
MacDougall, Heather
人类乳头瘤病毒和疫苗接种：意大利青少年和年轻妇女的知识，态度和行为意图。
影响因子：
8.8
作者：
Di Giuseppe, G.;Abbate, R.;Liguori, G.;Albano, L.;Angelillo, I. F.
通讯作者：
Angelillo, I. F.
影响因子：
12.4
作者：
Forni G;Mantovani A;COVID-19 Commission of Accademia Nazionale dei Lincei, Rome
通讯作者：
COVID-19 Commission of Accademia Nazionale dei Lincei, Rome